Anna Sendl-Lang

Title: Anna Sendl-Lang: Innovator in Subcutaneous Implant Technology

Introduction

Anna Sendl-Lang is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biomedical engineering, particularly in the development of subcutaneous implants. Her innovative work focuses on enhancing the efficacy and safety of these medical devices.

Latest Patents

Anna holds a patent for her invention titled "Subcutaneous implants containing a degradation-resistant polylactide polymer." This invention refers to compositions that comprise a LH-RH-analogue and/or pharmaceutically acceptable salts in a low-dose, along with a degradation-resistant polylactide suitable for the preparation of subcutaneous implants. Notably, the sterilization of the polylactide via gamma-radiation and temperature stress results in negligible decomposition of less than 1000 Dalton. This advancement is crucial for improving the longevity and reliability of subcutaneous implants.

Career Highlights

Anna Sendl-Lang is currently associated with Hexel AG, where she continues to push the boundaries of innovation in her field. Her work has garnered attention for its potential to revolutionize the way subcutaneous implants are designed and utilized in medical applications.

Collaborations

Throughout her career, Anna has collaborated with notable professionals in her field, including Kai-Thomas Kramer and Gregor Schütz. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Anna Sendl-Lang is a trailblazer in the realm of subcutaneous implant technology, with her innovative patent showcasing her commitment to improving medical devices. Her contributions are paving the way for future advancements in biomedical engineering.